• SENSEX 80,735.22
    -715.79 (--0.88%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Niva Bupa Health
    82.00 61.01(%)
  • Reliance Power
    60.76 60.50(%)
  • Mazagon Dock
    3,380.35 1,200.00(%)
  • Suzlon Energy
    73.44 86.04(%)
  • Garden Reach Sh.
    2,927.80 1,148.10(%)
  • Inox Wind
    201.00 262.10(%)
  • Genus Power
    430.05 485.85(%)
  • Cochin Shipyard
    1,900.55 1,180.45(%)
  • Indl. Inv. Trust
    168.35 145.80(%)
  • Titagarh Rail
    902.75 1,896.50(%)
  • Bharat Dynamics
    1,965.00 897.15(%)
  • SG Finserve
    445.00 546.00(%)
  • MMTC
    80.15 42.55(%)
  • Reliance Industr
    1,396.85 1,115.55(%)
  • St Bk of India
    809.10 679.65(%)
  • Eternal Ltd
    236.15 146.85(%)
  • IFCI
    65.96 35.67(%)
  • Bharat Electron
    388.40 393.55(%)
  • Jio Financial
    283.50 198.60(%)
  • Canara Bank
    116.50 129.35(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Titan Biotech Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 4349.0
  • ISIN : INE150C01011
458.70 1 (0.26%)
  • As on 02 Jun 2025 (EOD)

  • Today’s Low

    454.00

  • Today’s High

    463.90

  • Open

    463.90

  • Perv Close

    457.50

  • 52W Low

    406.70

  • 52W High

    1,017.85

Key Indicators

  • P/E(TTM)

    19.59

  • Mar.Cap (₹Cr.)

    379.06

  • Div & Yield %

    0.44

  • Book Value(₹)

    166.49

  • Debt-Equity Ratio

    0.26

  • AGM Date

    30-May-2025

  • EPS

    23.41

  • P/E Ratio

    19.59

Financials Ratios

  • Debt-Equity Ratio

    0.07

  • Mar.Cap (₹Cr.)

    379.06

  • RONW (%)

    19.44

  • ROCE (%)

    24.84

Score Board

  • Equity (₹ in Cr.)

    8.26

  • BV (₹)

    166.50

  • Sales( ₹ in Cr.)

    164.07

  • NP (in Cr.)

    23.66

  • NP Var(%)

    13.0

  • Div%

    20.0

  • CPS (₹)

    32.70

  • EPS (₹)

    28.60

  • Traded Value (₹ in Lakhs)

    379.06

  • 52 Week High

    1,017.85

  • 52 Week Low

    406.70

  • Price BSE

    459.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    379.06

  • P/C Ratio

    14.10

  • P/E Ratio

    16.00

  • Price Vs.BV

    28.60

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 164.07 144.00 123.55 122.46 69.48 58.24
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 164.07 144.00 123.55 122.46 69.48 58.24
Other Income 1.75 1.94 0.94 0.75 1.02 0.65
Stock Adjustments 5.29 0.93 0.17 2.23 0.65 3.88
Total Income 171.11 146.87 124.66 125.44 71.15 62.77
EXPENDITURE :            
Raw Materials 85.33 74.61 61.64 57.58 36.75 34.50
Power and Fuel Cost 10.24 8.98 6.67 4.10 3.53 3.22
Employee Cost 23.71 18.21 14.24 11.08 9.07 7.65
Other Manufacturing Expenses 4.10 3.44 2.96 3.77 1.36 0.70
Selling and Administration Expenses 10.75 9.21 6.42 5.66 8.40 8.09
Miscellaneous Expenses 0.95 0.96 0.52 1.05 0.15 0.50
Employee Benefit Expenses 23.71 18.21 14.24 11.08 9.07 7.65
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 135.07 115.42 92.46 83.23 59.25 54.66
Operating Profit 36.03 31.47 32.21 42.20 11.90 8.11
Interest 1.17 0.75 0.87 1.33 1.91 2.08
Gross Profit 34.86 30.72 31.34 40.87 9.99 6.03
Depreciation 3.33 2.60 2.37 2.10 1.75 1.68
Profit Before Tax 31.53 28.12 28.97 38.77 8.24 4.35
Current Tax 7.76 7.18 7.35 9.86 1.85 1.03
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.11 -0.09 -0.07 0.13 0.19 0.25
Reported Net Profit 23.66 21.02 21.68 28.77 6.20 3.08
Extraordinary Items 0.00 0.00 0.00 -0.24 0.46 -0.05
Adjusted Net Profit 23.66 21.02 21.68 29.01 5.74 3.13
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 89.00 69.22 48.77 20.83 14.62 11.54
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 1.49 1.24 1.24 0.83 0.00 0.00
P & L Balance carried down 111.18 89.00 69.22 48.77 20.83 14.62
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 20.00 18.00 15.00 15.00 10.00 0.00
Dividend Per Share(Rs) 2.00 1.80 1.50 1.50 1.00 0.00
Earnings Per Share-Unit Curr 28.64 25.44 26.24 34.82 7.50 3.73
Earnings Per Share(Adj)-Unit Curr 28.64 25.44 26.24 34.82 7.50 3.73
Book Value 155.43 128.38 104.36 79.65 45.76 38.31
Book Value(Adj)-Unit Curr 155.43 128.38 104.36 79.65 45.76 38.31

Shareholding Pattern

  • Promoter Group

    55.88%

  • Public Share Holding

    44.12%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,120,610 49.86 4,120,610 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 496,905 6.01 496,905 11
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,617,515 55.88 4,617,515 14
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 1,088 0.01 1,088 1
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,088 0.01 1,088 1
2] Non Institution
Bodies Corporate 151,757 1.84 147,757 49
Clearing Members 50 0.00 50 1
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 236,042 2.86 236,042 338
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 76,769 0.93 76,769 166
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 245,637 2.97 245,637 4
Individuals holding nominal share capital up to Rs. 1 lakh 2,167,559 26.23 1,920,648 15,795
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 766,883 9.28 766,883 1
Sub Total 3,645,097 44.11 3,394,186 16,355
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 8,263,700 100.00 8,012,789 16,370

Company Background

Titan Biotech LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Titan Biotech Ltd
  • BSE Code : 4349.0
  • ISIN : INE150C01011

  • Incorporation Year

    1992

  • Registered Office

    A-902 A RIICO Industrial Area
    Phase III Alwar District, Bhiwadi,
    Rajasthan-301019

  • Telephone

    91-011-27355742/27674615

  • FAX

    91-011-47619811

  • Chairman

    Rohit Jain

  • Managing Director

    Naresh Kumar Singla

  • Company Secretary

    Charanjit Singh

  • Auditor

    A N S K & Associates

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Beetal Fin.& Comp. Ser.(P) Ltd
    Beetal House 99 ,
    Madangir Behind LSC ,Nr Dada Harsukhdar
    Mumbai - Delhi - 110062

Titan Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Titan Biotech 458.70 165.82 164.07 19.59 25.70
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92